Future of molecular profiling of human hepatocellular carcinoma
- 1 August 2007
- journal article
- review article
- Published by Future Medicine Ltd in Future Oncology
- Vol. 3 (4), 429-439
- https://doi.org/10.2217/14796694.3.4.429
Abstract
Hepatocellular carcinoma (HCC) is a fatal disease occurring worldwide and developing mainly in chronic liver diseased patients. Despite routine screening of individuals at high risk, most of the patients are diagnosed at late stages of HCC. In addition, the recurrence rate after surgical resection of small tumors is high. Molecular profiling, including expression analysis, comparative genomics and proteomics, provides powerful tools to gain insight into the molecular mechanisms underlying carcinogenesis. Advances in bioinformatics have also allowed for the evaluation of large data sets. Therefore, molecular profiling of HCC using a Biological Expression Network Discovery (BLEND) strategy that integrates global molecular profiling data, including mRNA, miRNA, DNA methylation and DNA copy numbers from both the tumor and the surrounding microenvironment, along with mechanistic studies, may improve the diagnosis, treatment and prognosis of HCC patients. Such an approach will provide mechanistic insight into the pathogenesis of HCC, potentially leading to personalized medicine and the identification of new therapeutic targets.Keywords
This publication has 86 references indexed in Scilit:
- TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancerOncogene, 2007
- Prevention of Hepatocellular Carcinoma by Universal Vaccination against Hepatitis B Virus: The Effect and ProblemsClinical Cancer Research, 2005
- Hepatocellular carcinomaThe Lancet, 2003
- Translational strategies for cancer prevention in liverNature Reviews Cancer, 2003
- A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decadesProceedings of the National Academy of Sciences of the United States of America, 2002
- Molecular pathogenesis of human hepatocellular carcinomaNature Genetics, 2002
- Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC)Seminars in Cancer Biology, 2000
- The Hallmarks of CancerCell, 2000
- Rising Incidence of Hepatocellular Carcinoma in the United StatesNew England Journal of Medicine, 1999
- Universal Hepatitis B Vaccination in Taiwan and the Incidence of Hepatocellular Carcinoma in ChildrenNew England Journal of Medicine, 1997